Modeling Patient-Specific CAR-T Cell Dynamics: Multiphasic Kinetics via Phenotypic Differentiation.

Area of Science:

• Immunotherapy
• Mathematical Biology
• Oncology

Background:

• Chimeric Antigen Receptor (CAR)-T cell immunotherapy enhances T cell cancer-fighting capabilities.
• CAR-T cell responses exhibit complex multiphasic kinetics (distribution, expansion, contraction, persistence).
• Response dynamics vary based on tumor type, CAR-T product, and patient characteristics.

Purpose of the Study:

• To develop a mathematical model for multiphasic CAR-T cell dynamics.
• To incorporate patient and product heterogeneities into CAR-T cell behavior analysis.
• To identify potential biomarkers for predicting CAR-T cell therapy outcomes.

Main Methods:

• Developed a mathematical model simulating CAR-T and tumor cell interactions.
• Categorized CAR-T cells into functional, memory, and exhausted phenotypes.
• Analyzed CAR-T cell dynamics across diverse hematological cancers and patient profiles.

Main Results:

• The model accurately describes varied CAR-T cell dynamics in different patients and cancers.
• Identified distinct CAR-T cell phenotypes influencing therapeutic outcomes.
• Early CAR-T cell exposure (AUC) and non-exhausted cell fraction show potential as response markers.

Conclusions:

• Mathematical modeling provides insights into CAR-T cell therapy complexities.
• Understanding CAR-T cell phenotypes is crucial for optimizing immunotherapy.
• Joint assessment of early exposure and cell phenotype may predict treatment efficacy.